The alliance extends Insilico's PandaOmics and Chemistry42 platforms into pharmaceutical manufacturing for the first time, targeting a $168B CDMO industry.
The clearance raises questions about whether generative AI serves as an interface or a clinical decision-maker.
AI-powered clinical scribes are one of the fastest-adopted healthcare AI technologies, but their evolution will follow one of four distinct…
AI is reshaping pharmaceutical R&D from target identification through clinical trial optimization, compressing drug discovery timelines and unlocking therapeutic targets…
Medical educators must prioritize critical thinking over tool proficiency when teaching AI literacy to ensure future clinicians can safely overrule…